Accéder au contenu
Merck

SIRT1 regulates Mxd1 during malignant melanoma progression.

Oncotarget (2018-02-01)
Fabiana M Meliso, Danilo Micali, Camila T Silva, Thaís S Sabedot, Simon G Coetzee, Adrian Koch, Fabian B Fahlbusch, Houtan Noushmehr, Regine Schneider-Stock, Miriam G Jasiulionis
RÉSUMÉ

In a murine melanoma model, malignant transformation promoted by a sustained stress condition was causally related to increased levels of reactive oxygen species resulting in DNA damage and massive epigenetic alterations. Since the chromatin modifier Sirtuin-1 (SIRT1) is a protein attracted to double-stranded DNA break (DSB) sites and can recruit other components of the epigenetic machinery, we aimed to define the role of SIRT1 in melanomagenesis through our melanoma model. The DNA damage marker, γH2AX was found increased in melanocytes after 24 hours of deadhesion, accompanied by increased SIRT1 expression and decreased levels of its target, H4K16ac. Moreover, SIRT1 started to be associated to DNMT3B during the stress condition, and this complex was maintained along malignant progression.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anticorps anti-phospho-H2A.X (Ser139), Upstate®, from rabbit